The compounds are orally active, selective and reversible inhibitors of monoamine oxidase-B (MAO-B). They have favourable preclinical profiles, and were well tolerated and showed excellent pharmacokinetic properties in
This application is the first marketing approval submission for Orapem worldwide, and the first NDA submission the company has made. The Orapem submission is primarily based on data
The NDA submission is based on the results of 11 clinical trials, involving more than 1300 patients and subjects including two multi-center phase III clinical trials conducted in
Fay Guarraci, assistant professor of psychology at Southwestern University, and Stacey Benson, a 2005 Southwestern graduate, gave 108 female rats a moderate dose of caffeine before a mating
Under the research collaboration, Roche will use its screening capabilities to investigate three mutually agreed targets in the field of inflammatory diseases. Amira will then utilize its expertise
The 200 patient study is designed to assess both the safety of Androxal and its efficacy in restoring normal pituitary and testicular function in men that are hypogonadal
More than 300 patients enrolled in the trial to evaluate the efficacy of daily administration of the drug as treatment for the abnormal fat accumulation and distribution associated
This approval of the intravenous form of the drug will provide an alternative for patients who have difficulty with oral bisphosphonate dosing requirements, including an inability to sit
Cangen has commenced patient recruitment for a study at clinical sites in Asia and will receive funding from Olympus in support of the study and ongoing research and
“This acquisition will strengthen China Biopharmaceuticals’ market position, as we increase our manufacturing capacity to supplement our continued expansion in our marketing and distribution channels,” said Chris Mao,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.